Safety of Treatment Regimens Containing Bedaquiline and Delamanid in the endTB Cohort( )

BACKGROUND: Safety of treatment for multidrug-resistant tuberculosis (MDR/RR-TB) can be an obstacle to treatment completion. Evaluate safety of longer MDR/RR-TB regimens containing bedaquiline and/or delamanid. METHODS: Multicentre (16 countries), prospective, observational study reporting incidence...

Descripción completa

Detalles Bibliográficos
Autores principales: Hewison, Catherine, Khan, Uzma, Bastard, Mathieu, Lachenal, Nathalie, Coutisson, Sylvine, Osso, Elna, Ahmed, Saman, Khan, Palwasha, Franke, Molly F, Rich, Michael L, Varaine, Francis, Melikyan, Nara, Seung, Kwonjune J, Adenov, Malik, Adnan, Sana, Danielyan, Narine, Islam, Shirajul, Janmohamed, Aleeza, Karakozian, Hayk, Kamene Kimenye, Maureen, Kirakosyan, Ohanna, Kholikulov, Begimkul, Krisnanda, Aga, Kumsa, Andargachew, Leblanc, Garmaly, Lecca, Leonid, Nkuebe, Mpiti, Mamsa, Shahid, Padayachee, Shrivani, Thit, Phone, Mitnick, Carole D, Huerga, Helena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9522425/
https://www.ncbi.nlm.nih.gov/pubmed/35028659
http://dx.doi.org/10.1093/cid/ciac019

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9522425/
https://www.ncbi.nlm.nih.gov/pubmed/35028659
http://dx.doi.org/10.1093/cid/ciac019

Ejemplares similares